Home / Market News / $LUNG

$LUNG news and market catalysts

The 5 most recent market catalysts affecting $LUNG, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

5 catalysts 0 high impact 3 bullish 1 bearish Medical Devices
Nov 17, 2026 Corporate Catalyst Neutral Impact 65
Pulmonx Announces Publication of CONVERT Trial Results for AeriSealĀ® System
Pulmonx announced the publication of positive results from its CONVERT trial for the AeriSeal System. The study showed that 75.8% of patients successfully converted to collateral v…
Oct 28, 2026 Corporate Catalyst Bullish Impact 75
Pulmonx Reports Third Quarter 2026 Financial Results
Pulmonx Corporation announced its third-quarter 2026 financial results, showing a 6% year-over-year increase in worldwide revenue and a substantial narrowing of its net loss and Ad…
Jul 29, 2026 Corporate Catalyst Bearish Impact 75
Pulmonx shares are trading lower after the company announced an offering.
The announcement of a stock offering by Pulmonx (LUNG) is a significant corporate catalyst, almost always leading to negative price action for the issuing company. This is due to t…
Jul 29, 2026 Corporate Catalyst Bullish Impact 75
Pulmonx shares are trading higher after the company reported better-than-expected Q2 financial results.
This headline signifies a direct positive corporate catalyst for Pulmonx (LUNG). Better-than-expected financial results typically lead to increased investor confidence, driving up …
Jul 29, 2026 Corporate Catalyst Bullish Impact 55
Pulmonx Q2 EPS $(0.24) Beats $(0.28) Estimate, Sales $22.756M Beat $22.400M Estimate
The headline indicates Pulmonx (LUNG) exceeded analyst expectations for both earnings per share and revenue in Q2. This positive surprise typically leads to an immediate positive r…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.